MedTrace Logo

A Novel Usage of Transdermal Scopolamine in Reducing Narcotic Usage in Outpatient Hand Surgery

NCT04008264 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 74

Last updated 2022-09-08

No results posted yet for this study

Summary

The investigators will examine and analyze opioid narcotic usage patterns by requesting patients keep a two week log of their opioid usage following outpatient hand surgery with a standard analgesic regimen consisting of an opioid, NSAID, and acetaminophen. Following a pre-intervention period, the investigators will add scopolamine to the regimen and have patients monitor their opioid consumption. The investigators will then compare opioid consumption patterns following completion of the study.

Conditions

  • Post Operative Pain Management

Interventions

DRUG

Scopolamine Patch (Transderm V)

During the observational phase, patients will be given a prescription for an 18 day supply of scopolamine, and patients will record the same data as prior to the intervention.

Sponsors & Collaborators

  • Alexander M Spiess, MD

    lead OTHER

Principal Investigators

  • Alexander Spiess, MD · University of Pittsburgh

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-25
Primary Completion
2022-07-01
Completion
2022-07-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04008264 on ClinicalTrials.gov